BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 12598139)

  • 1. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99.
    Antoine C; Müller S; Cant A; Cavazzana-Calvo M; Veys P; Vossen J; Fasth A; Heilmann C; Wulffraat N; Seger R; Blanche S; Friedrich W; Abinun M; Davies G; Bredius R; Schulz A; Landais P; Fischer A; ;
    Lancet; 2003 Feb; 361(9357):553-60. PubMed ID: 12598139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?
    Gennery AR; Slatter MA; Grandin L; Taupin P; Cant AJ; Veys P; Amrolia PJ; Gaspar HB; Davies EG; Friedrich W; Hoenig M; Notarangelo LD; Mazzolari E; Porta F; Bredius RG; Lankester AC; Wulffraat NM; Seger R; Güngör T; Fasth A; Sedlacek P; Neven B; Blanche S; Fischer A; Cavazzana-Calvo M; Landais P; ;
    J Allergy Clin Immunol; 2010 Sep; 126(3):602-10.e1-11. PubMed ID: 20673987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation: a retrospective European survey from the European group for bone marrow transplantation and the european society for immunodeficiency.
    Bertrand Y; Landais P; Friedrich W; Gerritsen B; Morgan G; Fasth A; Cavazzana-Calvo M; Porta F; Cant A; Espanol T; Müller S; Veys P; Vossen J; Haddad E; Fischer A
    J Pediatr; 1999 Jun; 134(6):740-8. PubMed ID: 10356144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
    Buckley RH; Schiff SE; Schiff RI; Markert L; Williams LW; Roberts JL; Myers LA; Ward FE
    N Engl J Med; 1999 Feb; 340(7):508-16. PubMed ID: 10021471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism.
    Eapen M; Ahn KW; Orchard PJ; Cowan MJ; Davies SM; Fasth A; Hassebroek A; Ayas M; Bonfim C; O'Brien TA; Gross TG; Horwitz M; Horwitz E; Kapoor N; Kurtzberg J; Majhail N; Ringden O; Szabolcs P; Veys P; Baker KS
    Biol Blood Marrow Transplant; 2012 Sep; 18(9):1438-45. PubMed ID: 22430083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency.
    Hassan A; Lee P; Maggina P; Xu JH; Moreira D; Slatter M; Nademi Z; Worth A; Adams S; Jones A; Cale C; Allwood Z; Rao K; Chiesa R; Amrolia P; Gaspar H; Davies EG; Veys P; Gennery A; Qasim W
    J Allergy Clin Immunol; 2014 Jun; 133(6):1660-6. PubMed ID: 24794685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.
    Güngör T; Teira P; Slatter M; Stussi G; Stepensky P; Moshous D; Vermont C; Ahmad I; Shaw PJ; Telles da Cunha JM; Schlegel PG; Hough R; Fasth A; Kentouche K; Gruhn B; Fernandes JF; Lachance S; Bredius R; Resnick IB; Belohradsky BH; Gennery A; Fischer A; Gaspar HB; Schanz U; Seger R; Rentsch K; Veys P; Haddad E; Albert MH; Hassan M;
    Lancet; 2014 Feb; 383(9915):436-48. PubMed ID: 24161820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-haploidentical transplantations for primary immunodeficiencies: a single-center experience.
    Cipe FE; Dogu F; Aytekin C; Yuksek M; Kendirli T; Yildiran A; Bozdogan G; Karatas D; Reisli I; Dalva K; Arpacı F; Ikinciogullari A
    Pediatr Transplant; 2012 Aug; 16(5):451-7. PubMed ID: 22594916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Features and HSCT Outcome for SCID in Turkey.
    Ikinciogullari A; Cagdas D; Dogu F; Tugrul T; Karasu G; Haskologlu S; Aksoylar S; Uygun V; Kupesiz A; Yildiran A; Gursel O; Ates C; Elhan A; Kansoy S; Yesilipek A; Tezcan I;
    J Clin Immunol; 2019 Apr; 39(3):316-323. PubMed ID: 30924026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hematopoietic stem cell transplantation in children with primary immunodeficiencies].
    Kelecić J; Rajić L; Tjesić-Drinković D
    Acta Med Croatica; 2009 Jun; 63(3):255-8. PubMed ID: 19827355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.
    Schuetz C; Neven B; Dvorak CC; Leroy S; Ege MJ; Pannicke U; Schwarz K; Schulz AS; Hoenig M; Sparber-Sauer M; Gatz SA; Denzer C; Blanche S; Moshous D; Picard C; Horn BN; de Villartay JP; Cavazzana M; Debatin KM; Friedrich W; Fischer A; Cowan MJ
    Blood; 2014 Jan; 123(2):281-9. PubMed ID: 24144642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources.
    Souillet G; Guffon N; Maire I; Pujol M; Taylor P; Sevin F; Bleyzac N; Mulier C; Durin A; Kebaili K; Galambrun C; Bertrand Y; Froissart R; Dorche C; Gebuhrer L; Garin C; Berard J; Guibaud P
    Bone Marrow Transplant; 2003 Jun; 31(12):1105-17. PubMed ID: 12796790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
    Huang X; Liu D
    Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.
    Bacchetta R; Bigler M; Touraine JL; Parkman R; Tovo PA; Abrams J; de Waal Malefyt R; de Vries JE; Roncarolo MG
    J Exp Med; 1994 Feb; 179(2):493-502. PubMed ID: 7905018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients.
    Bielorai B; Trakhtenbrot L; Amariglio N; Rothman R; Tabori U; Dallal I; Golan H; Neumann Y; Reichart M; Kaplinsky C; Rechavi G; Toren A
    Bone Marrow Transplant; 2004 Aug; 34(4):317-20. PubMed ID: 15220954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating red cells usually remain of host origin after bone marrow transplantation for severe combined immunodeficiency.
    Brady KA; Cowan MJ; Leavitt AD
    Transfusion; 1996 Apr; 36(4):314-7. PubMed ID: 8623130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher CD34(+) and CD3(+) cell doses in the graft promote long-term survival, and have no impact on the incidence of severe acute or chronic graft-versus-host disease after in vivo T cell-depleted unrelated donor hematopoietic stem cell transplantation in children.
    Kałwak K; Porwolik J; Mielcarek M; Gorczyńska E; Owoc-Lempach J; Ussowicz M; Dyla A; Musiał J; Paździor D; Turkiewicz D; Chybicka A
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1388-401. PubMed ID: 20382248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Laboratory Factors Affecting the Prognosis of Severe Combined Immunodeficiency.
    Ozturk E; Catak MC; Kiykim A; Baser D; Bilgic Eltan S; Yalcin K; Kasap N; Nain E; Bulutoglu A; Akgun G; Can Y; Sefer AP; Babayeva R; Caki-Kilic S; Tezcan Karasu G; Yesilipek A; Ozen A; Karakoc-Aydiner E; Baris S
    J Clin Immunol; 2022 Jul; 42(5):1036-1050. PubMed ID: 35451701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.